Lv4
580 积分 2025-07-22 加入
Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy
5天前
已完结
Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy
5天前
已完结
Daraxonrasib for Previously Treated RAS-Mutant Non–Small-Cell Lung Cancer
11天前
已完结
Epigenetic memory in response to environmental stressors
12天前
已完结
MONARCH 2: Subgroup Analysis of Patients Receiving Abemaciclib Plus Fulvestrant as First-Line and Second-Line Therapy for HR+, HER2−-Advanced Breast Cancer
16天前
已完结
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2
16天前
已完结
Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer
16天前
已完结
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
16天前
已完结
Lorlatinib versus crizotinib as first-line treatment for advanced ALK-positive non-small-cell lung cancer: 7-year update from the phase III CROWN study
25天前
已完结
Lorlatinib versus crizotinib as first-line treatment for advanced ALK-positive non-small-cell lung cancer: 7-year update from the phase III CROWN study
25天前
已完结
皖公网安备34019202002308
